Loading clinical trials...
Loading clinical trials...
This is a multi-center prospective registry of patients with an ejection fraction (EF) ≤ 35% following coronary artery bypass graft (CABG) surgery in order to test the hypothesis that wearable defibri...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Zoll Medical Corporation
NCT07201506 · Ablation of Arrhythmias, Premature Ventricular Contractions, and more
NCT07148089 · Catecholaminergic Polymorphic Ventricular Tachycardia
NCT06371729 · Ventricular Tachycardia
NCT05373940 · Heart Failure, Primary Prevention of Sudden Cardiac Death, and more
NCT04162171 · Ventricular Tachycardia, Myocardial Infarction, and more
Sutter Heart and Vascular Institute
Sacramento, California
Saint Joseph's Health System, Inc.
Atlanta, Georgia
Washington Adventist Hospital
Takoma Park, Maryland
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions